Sciencast Management’s Integra LifeSciences IART Stock Holding History

Sciencast Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$619K	Buy	+11,194	New	+$672K	0.14%	214
2022 Q1	–	Sell	-13,941	Closed	-$969K	–	640
2021 Q4	$969K	Buy	+13,941	New	+$943K	0.17%	184
2021 Q3	–	Sell	-4,212	Closed	-$287K	–	485
2021 Q2	$287K	Buy	+4,212	New	+$298K	0.06%	379
2021 Q1	–	Sell	-12,603	Closed	-$811K	–	575
2020 Q4	$811K	Buy	+12,603	New	+$678K	0.17%	189
2020 Q3	–	Sell	-10,428	Closed	-$486K	–	471
2020 Q2	$486K	Buy	+10,428	New	+$513K	0.12%	269
2020 Q1	–	Sell	-4,329	Closed	-$248K	–	436
2019 Q4	$248K	Buy	+4,329	New	+$258K	0.07%	401
2016 Q4	–	Sell	-5,200	Closed	-$215K	–	210
2016 Q3	$215K	Buy	+5,200	New	+$218K	0.64%	72

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Sciencast Management's IART Position: Q2 2022 in Review

Sciencast Management opened a new position in Integra LifeSciences (IART) in Q2 2022: 11,194 shares worth $619K. The stake represents 0.14% of the portfolio and ranks #214 among its holdings. This is a return to the name: Sciencast Management previously reported a position in IART as recently as Q4 2021.

Sciencast Management first reported a position in IART in Q3 2016 and has held it in 7 quarters since. The position peaked at $969K in Q4 2021. 284 funds tracked by Wall St. Rank hold IART as of Q2 2022.

Sciencast Management held 11,194 shares of Integra LifeSciences worth $619K as of Q2 2022.
Integra LifeSciences was a new Sciencast Management position in Q2 2022.
Integra LifeSciences made up 0.14% of Sciencast Management's portfolio in Q2 2022, its #214 holding.
Sciencast Management first reported a position in Integra LifeSciences in Q3 2016 and has held it in 7 quarters since.
Sciencast Management's Integra LifeSciences position peaked at $969K in Q4 2021.
284 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2022.

Based on Sciencast Management's 13F filing for Q2 2022, filed 3 Aug 2022.